Association between Helicobacter pylori and otitis media with effusion in children: A systematic review

Peiyu Du1, Shimin Zong1, Yingying Wen1

  • 1Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Insights

Helicobacter pylori (H. pylori) infection is linked to otitis media with effusion (OME) in children. Higher H. pylori detection rates were found in children with OME, suggesting potential benefits from H. pylori eradication for resistant cases.

Area of Science:

  • Pediatric infectious diseases
  • Otolaryngology
  • Microbiology

Background:

  • Helicobacter pylori (H. pylori) infection is increasingly recognized as a potential factor in pediatric otitis media with effusion (OME).
  • Understanding this association is crucial for developing effective treatment strategies for OME.

Purpose of the Study:

  • To systematically review and analyze the existing literature on the relationship between H. pylori infection and OME in children.
  • To explore the prevalence of H. pylori in various specimens from pediatric OME patients.

Main Methods:

  • A comprehensive literature search was conducted across major databases (PubMed, Web of Science, Ovid, CNKI, Wanfang) up to October 30, 2019.
  • Included studies were assessed for quality, and data were extracted for qualitative analysis due to heterogeneity.
  • Ten case-control studies involving 397 cases and 334 controls were included.

Main Results:

  • H. pylori detection rates were significantly higher in the middle ear, tonsils, and gastric juice of children with OME compared to controls.
  • No conclusive difference was found in H. pylori detection rates in adenoid specimens between OME and non-OME groups.
  • Qualitative analysis was performed due to significant heterogeneity among studies, precluding meta-analysis.

Conclusions:

  • The findings suggest a potential link between H. pylori and OME in children, particularly in specific anatomical sites.
  • Eradication of H. pylori may offer therapeutic benefits for drug-resistant OME cases.
  • Further high-quality research is essential to solidify these conclusions and guide clinical practice.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
919
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
660
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
448
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
1.4K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
975
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
341